KAL
15.1.2020 17:02:12 CET | Business Wire | Press release
In a world first, KAL ATM Software and Česká spořitelna have rolled out the first ATM running Windows 10 on a Linux Hypervisor.
KAL’s new Kalignite Hypervisor solution, in partnership with Red Hat, is a game-changing solution that allows banks to break free from enforced, costly and disruptive ATM hardware upgrades.
It uses OS-Virtualization technology to solve the long-standing problem of enforced ATM hardware upgrades and decouples the ATM PC-core from the ATM operating system so that software drivers that are unsupported under new Windows operating system versions can be supported by the Linux drivers instead.
Česká spořitelna’s ATM Software Innovation product owner, Jakub Otáhal, explains that the end of support for Windows 7, and the accompanying expense and complexity of upgrading ATM hardware and software to Windows 10, prompted the decision to install Kalignite Hypervisor in a pilot production environment.
He said: “KAL’s new solution gives Česká spořitelna control over when to carry out hardware upgrades. This means we can cut costs by keeping to our 10-11 year renewal recycle, rather than being forced to comply with the hardware lifetime. Very importantly, Kalignite Hypervisor also enables us to keep our software right up to date.”
KAL CEO Aravinda Korala added: “We are delighted that Česká spořitelna decided to partner with us to achieve this impressive world first. Kalignite Hypervisor enables Česká spořitelna to stay completely up to date and run the latest versions of all software on their ATMs. Not only does this technology help with the Windows 10 migration, it also allows Česká spořitelna to migrate to new Windows LTSC and SAC upgrades without requiring hardware changes.”
About Česká spořitelna
Česká spořitelna is the largest bank in the Czech Republic with more than four million clients and the most extensive branch and ATM networks in the country. It provides services for individuals, small and medium-sized enterprises, towns and municipalities, and finances large corporations.
Česká spořitelna is proud of its long tradition – it was established in 1825 as the first savings bank in the Czech Republic – but it is equally proud of its role as an innovator. Many of its products and services are leaders in the Czech market. The bank has been a member of the Erste Group since 2000.
For more information, visit www.csas.cz/en/about-us/who-we-are
About KAL
KAL is a world-leading ATM software company and the preferred supplier to mega-banks such as Citibank, UniCredit, ING and China Construction Bank.
KAL’s software gives banks full control of their ATM network, reducing costs, meeting all security needs and improving competitiveness. It is installed and supported in more than 80 countries.
For more information, visit www.kal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200115005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ThetaRay Named World’s Best Software Provider for AML and Sanctions Screening in the 2026 Euromoney Transaction Banking Awards5.11.2026 19:30:00 CET | Press release
Recognition caps standout year alongside ThetaRay’s Top 10 (#8) ranking in the 2026 Chartis Financial Crime and Compliance50 (FCC50) and category win for Explainable AI. ThetaRay, a global leader in AI-native financial crime compliance infrastructure, has been named The World’s Best Software Provider for AML and Sanctions Screening at the 2026 Euromoney Transaction Banking Awards. Evaluated by Euromoney’s editorial and research team, ThetaRay was recognized for technology excellence, verifiable performance, and advancing the modern transaction banking value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105714764/en/ The recognition reinforces ThetaRay’s standing as foundational compliance infrastructure for global institutions, closely following Chartis Research ranking ThetaRay #8 globally in the Financial Crime and Compliance50 (FCC50) 2026 report and naming the company a Category Winner for Explainable AI. “Our
Arthur D. Little: H1 2026 Private Capital Fundraising Strengthens While Market Sentiment Highlights Investor Shift to Europe over US and Asia5.11.2026 18:58:00 CET | Press release
H1 fundraising up 6% year-on-year as 43% of LPs see geopolitical volatility favouring European funds AI usage dominates industry attention, defence leads target investment themes Invest Europe, the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors, today released ‘Investing in Europe: Private Equity Activity H1 2026’ and ‘The Insight: State of the European Private Equity Industry 2026’, an annual market sentiment report published jointly with global management consultancy Arthur D. Little (ADL). Together, these show increased fundraising for European private equity and venture capital versus the same period last year, stronger investor allocation expectations for Europe, and declining appetite for the US and Asia. The sentiment report also demonstrates how AI is reshaping the industry and portfolio companies, while defence-related themes are topping GPs’ target investments. GPs (General Partners/fund managers of PE
Angelalign Appoints Marco Gadola as Senior Advisor5.11.2026 18:35:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco will advise the Board and senior management on culture, strategy and governance. Marco, who has held many leadership positions, is well-known as a former CEO of Straumann Group, a leading global medical device company focused on dentistry. Marco said he is excited to join Angel. “I’ve followed Angel for 10 years and have seen how it has evolved,” he said, “It’s grown from a regional leader in innovative clinical solutions and high-quality products, to a worldwide organization trusted by orthodontic specialists, with an impressive innovation pipeline.” Fox Hu, CEO of Angel, said: “Angel has strong core capabilities, but we must continue to improve to serve orthodontists even better. We welcome Marco as an advocate for our customers and employees around the world and to help us build an outstan
Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms5.11.2026 17:25:00 CET | Press release
Boomi governs agents, with flexibility across cloud, hybrid, and fully on-premises deployments behind the firewall. Boomi, the data activation company for AI, today announced it has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. Boomi delivers agent management capabilities through the Agent Control Plane. Boomi believes this placement reflects its approach to solving one of the biggest hurdles in turning AI into ROI, by providing critical AI infrastructure that connects, governs, and controls AI costs across agents and skills from native and third-party providers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105515847/en/ Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms Key Takeaways Boomi has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. A complimentary copy of t
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products5.11.2026 16:04:00 CET | Press release
Biocodex, an independent French pharmaceutical company, announces a €15 million investment to develop an industrial platform in Beauvais, France, dedicated to Live Biotherapeutic Products (LBPs) derived from the microbiome. Building on more than 70 years of expertise in living microorganisms, microbiota, fermentation and pharmaceutical manufacturing, Biocodex aims to support its partners and, ultimately, its own programs, from research through to clinical and commercial production. The project aims to strengthen healthcare and industrial sovereignty in the field of next-generation microbiome-based therapies. Scientific advances in microbiome science are opening up new therapeutic perspectives, notably in oncology, inflammatory bowel diseases, certain rare diseases and women’s health. Moving from research to pharmaceutical production requires facilities adapted to living microorganisms and pharmaceutical requirements. Open to biotechnology companies worldwide, it will support LBP progra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom